CDH
STJ

Charles D. Hyman’s St Jude Medical STJ Stock Holding History

Charles D. Hyman’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,800
Closed -$946K – 153
2016
Q4 		$946K Hold
11,800
– – 0.13% 90
2016
Q3 		$941K Hold
11,800
– – 0.14% 89
2016
Q2 		$920K Hold
11,800
– – 0.14% 88
2016
Q1 		$649K Hold
11,800
– – 0.1% 94
2015
Q4 		$729K Hold
11,800
– – 0.12% 94
2015
Q3 		$744K Hold
11,800
– – 0.13% 94
2015
Q2 		$862K Hold
11,800
– – 0.14% 90
2015
Q1 		$772K Hold
11,800
– – 0.12% 92
2014
Q4 		$767K Hold
11,800
– – 0.12% 93
2014
Q3 		$710K Hold
11,800
– – 0.12% 95
2014
Q2 		$817K Hold
11,800
– – 0.14% 95
2014
Q1 		$772K Hold
11,800
– – 0.14% 95
2013
Q4 		$731K Hold
11,800
– – 0.13% 95
2013
Q3 		$633K Hold
11,800
– – 0.13% 96
2013
Q2 		$538K Buy
+11,800
New +$511K 0.11% 100

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Charles D. Hyman's STJ Position: Q1 2017 in Review

Charles D. Hyman sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 11,800 shares — an estimated $946K sold.

Charles D. Hyman first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $946K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Charles D. Hyman reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Charles D. Hyman sold 11,800 St Jude Medical shares in Q1 2017, an estimated $946K.
  • Charles D. Hyman first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Charles D. Hyman's St Jude Medical position peaked at $946K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Charles D. Hyman's 13F filing for Q1 2017, filed 11 May 2017.